960305-55-9 (tert-butyl 7-(hydroxymethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate,tert-butyl 7-(hydroxymethyl)-1,2,3,4-tetrahydroisoquinoline-2-carboxylate)

CAS号:
960305-55-9
中文名称:
tert-butyl 7-(hydroxymethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate
英文名称:
tert-butyl 7-(hydroxymethyl)-1,2,3,4-tetrahydroisoquinoline-2-carboxylate
分子式:
C15H21NO3
分子量:
263.332144498825

tert-butyl 7-(hydroxymethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate(960305-55-9)名称与标识符

名称

中文别名:
7-(羟基甲基)-3,4-二氢异喹啉-2(1H)-羧酸叔丁酯;
英文别名:
tert-butyl 7-(hydroxymethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate;2-Boc-1,2,3,4-tetrahydro-isoquinoline-7-methanol;tert-butyl 7-(hydroxymethyl)-3,4-dihydro-1H-isoquinoline-2-carboxylate;2-Boc-1,2,3,4-tetrahydroisoquinoline-7-methanol;tert-Butyl 7-(hydroxymethyl)-1,2,3,4-tetrahydroisoquinoline-2-carboxylate;PB21151;SY251562;tert-Butyl-7-(hydroxymethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate;1,1-Dimethylethyl 3,4-dihydro-7-(hydroxymethyl)-2(1H)-isoquinolinecarboxylate (ACI);

标识符

MDL:
MFCD12408146
InChIKey:
CIBOPYLOTAXPDB-UHFFFAOYSA-N
Inchi:
1S/C15H21NO3/c1-15(2,3)19-14(18)16-7-6-12-5-4-11(10-17)8-13(12)9-16/h4-5,8,17H,6-7,9-10H2,1-3H3
SMILES:
O=C(N1CCC2C(=CC(CO)=CC=2)C1)OC(C)(C)C

tert-butyl 7-(hydroxymethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate(960305-55-9)物化性质

计算特性

  • 氢键供体数量 : 1
  • 氢键受体数量 : 3
  • 可旋转化学键数量 : 3
  • 重原子数量 : 19
  • 复杂度 : 324
  • 疏水参数计算参考值(XlogP) : 1.8
  • 拓扑分子极性表面积 : 49.8

tert-butyl 7-(hydroxymethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate(960305-55-9)推荐厂家 更多厂家(7)

tert-butyl 7-(hydroxymethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate(960305-55-9)合成路线

合成路线:1 步
反应条件:
参考文献:
Preparation of nitrogen-containing heterocyclic compounds and its medical application
, China, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of phenalkylamine derivatives as GlyT1 inhibitors
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of amidine derivatives as FXa inhibitors
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of aza-tetrahydronaphthyridine compounds for treating or preventing autoimmune diseases or chronic inflammatory diseases
, China, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of substituted phenylacetic acids as DP-2 antagonists
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of fused heterocyclic M1 receptor positive allosteric modulators
, World Intellectual Property Organization, , ,